In 1983, Juan Rosai and colleagues introduced the term "gastrointestinal stromal tumor (GIST)" to describe gastrointestinal mesenchymal tumors that lacked clear smooth muscle or nerve sheath differentiation.
A major breakthrough occurred in 1998, when Hirota Seiichi and colleagues discovered activating mutations in the KIT proto-oncogene (CD117) in most GISTs
No comments:
Post a Comment